OncXerna Therapeutics Company
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Headquarters:
Waltham, Massachusetts, United States
Last Funding Type:
Series B
Employee Number:
11-50
Total Funding:
96500000
Founded Date:
2018-01-01
Industry:
Gene therapy
Funding Status:
Early Stage Venture